Keywords: cell, trisenox, shows, good, performance, advanced, myeloma

Cell's Trisenox shows good performance in advanced myeloma

Article | 25 April 2005

Print This

Cell Therapeutics of the USA has reported strong results for its anticancer agent Trisenox (arsenic trioxide) in patients with late-stage, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in